Wednesday, 21 April, 2021

REVISIONS TO THE ANTI-DOPING SINGAPORE (ADS) THERAPEUTIC USE EXEMPTION (TUE) POLICY

The ADS TUE Policy has been revised to include changes to the 2017 Prohibited List. The key revisions to the ADS TUE Policy is to Section 4 (Procedure for Asthma Treated with Beta-2 Agonists) on the refinements and guidelines for the thresholds of permitted Beta-2 Agonists for treatment of asthma.

A copy of the revised ADS TUE policy with effect from 1 January 2017 is attached for your information. You may also download a copy of the TUE Policy from the ADS website at www.antidoping.org.sg.

The 2017 Prohibited List has taken effect on 1 January 2017.  Athletes and officials can check the status of their medication prescribed or bought over-the-counter at pharmacies in Singapore by using the online database “CheckDrugs” which is accessible from Anti-Doping Singapore’s (ADS) website at www.antidoping.org.sg.

Similar Articles

NEWS